NEW YORK, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG

NEW YORK, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences, Inc. (“Bright Minds,” “BMB” o

Does Bright Minds Biosciences Inc. (DRUG) have what it takes to be a top stock pick for momentum inv

The average of price targets set by Wall Street analysts indicates a potential upside of 97% in Brig

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Bright Minds Biosciences (NASDAQ:D

BTIG analyst Thomas Shrader reiterates Bright Minds Biosciences (NASDAQ:DRUG) with a Buy and main

The mean of analysts' price targets for Bright Minds Biosciences Inc. (DRUG) points to a 97.4% upsid

SOUTH SAN FRANCISCO, Calif., July 31, 2026 (GLOBE NEWSWIRE) -- Vistagen (Nasdaq: VTGN), a late clini

The consensus price target hints at a 107.5% upside potential for Bright Minds Biosciences Inc. (DRU

Bright Minds Biosciences Inc. (DRUG) might move higher on growing optimism about its earnings prospe

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Bright Minds Biosciences (NASDAQ:D

NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences, Inc. (“Bright Minds,” “BMB” or

Bright Minds Biosciences develops serotonin-based therapeutics for neurological and neuropsychiatric

Piper Sandler analyst Yasmeen Rahimi maintains Bright Minds Biosciences (NASDAQ:DRUG) with a Over

https://www.hhs.gov/press-room/fda-accelerates-action-treatments-serious-mental-illness-following-ex

https://www.cbsnews.com/news/psychedelic-drug-ibogaine-ptsd-trump-to-sign-executive-order/

Jefferies analyst Andrew Tsai initiates coverage on Bright Minds Biosciences (NASDAQ:DRUG) with a

BTIG analyst Thomas Shrader reiterates Bright Minds Biosciences (NASDAQ:DRUG) with a Buy and main

Bright Minds Biosciences Inc. (NASDAQ: DRUG - Get Free Report) has been given a consensus recommenda

https://www.marijuanamoment.net/bipartisan-senators-file-bill-to-support-psychedelics-research-and-t

HC Wainwright & Co. analyst Patrick R. Trucchio maintains Bright Minds Biosciences (NASDAQ:DR

NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences, Inc. (“Bright Minds,” “BMB” or

BTIG analyst Thomas Shrader maintains Bright Minds Biosciences (NASDAQ:DRUG) with a Buy and maint

Bright Minds Biosciences Inc. (NASDAQ: DRUG - Get Free Report) has been assigned an average rating o

NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG)

NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG)

Bright Minds Biosciences remains a "Strong Buy" after positive phase 2 data for BMB-101 in drug-resi

NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG)

Bright Minds Biosciences Inc. (NASDAQ: DRUG) stock is trading higher on Tuesday after the company sh

NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (Nasdaq: DRUG)

Shares of Bright Minds Biosciences Inc (NASDAQ: DRUG, CSE:DRUG) jumped almost 25% after the company

https://www.marijuanamoment.net/house-votes-to-let-va-doctors-recommend-medical-mari

https://www.marijuanamoment.net/rfk-says-trump-administration-could-provide-psychedelic-therapy-to-m

https://www.statnews.com/2025/06/18/fda-approval-psychedelics-rfk-jr-trump-allies-see-opening-mdma-p

https://www.marijuanamoment.net/alaska-activists-launch-campaign-to-put-psychedelics-legalization-me

  Tuesday saw 132 companies set new 52-week lows.

  On Thursday, 369 companies hit new 52-week lows.

  Monday's session saw 175 companies set new 52-week lows.

  Friday's session saw 225 companies set new 52-week lows.

  On Thursday, 283 companies set new 52-week lows.

Gainers Tango Therapeutics, Inc. (NASDAQ: TNGX) climbed 85.2% to $7.09 after gaining 11% on Tuesd